During the GS1 Healthcare Conference organised on 8-10 May 2018 in Ethiopia, more than 310 participants met to share how they are using GS1 standards to help solve one of the world’s most pressing patient safety issues: falsified medicines.
According to the World Health Organisation, an estimated 1 in 10 medical products circulating on low- and middle-income countries is either substandard or falsified. This means that people are taking medications that either fail to treat or prevent disease or could be harmful. Falsified medical products lead to a loss of lives, negatively impact economic growth and erode overall trust in the healthcare system.
Organised by GS1, hosted by the Ethiopian Food, Medicine and Healthcare Administration and Control Authority (EFMHACA) and supported by the United States Agency for International Development (USAID), the African GS1 Healthcare Conference brought together determined and inspired professionals who understand that securing the global healthcare supply chain enabled by GS1 standards is a ‘’marathon, not a sprint.’’
Eminent speakers delivered presentations on medicines traceability, pharmaceutical serialisation and traceability, vaccines traceability, traceability for patient safety amongst others.
Legend: Mr. Teddy Berihun, Senior Health Information Systems Adviser, USAID, Ethiopia during his intervention on traceability progress in Ethiopia